MEDIPAL HOLDINGS Corporation

MEDIPAL HOLDINGS Corporation

20.20
USD
+0.10
(+0.50%)
1.69EPS
11.60P/E
3.31BMarket Cap
Feb 03Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
13,044.85
12,703.27
13,375.28
13,533.49
13,944.97
14,271.72
15,064.8
15,296.33
15,676.29
16,005.38
16,806.03
17,612.38
18,551.12
18,818.98
Basic EPS, GAAP
112.78
104.74
135.91
128.14
154.15
154.11
175.83
113.97
140.16
184.85
195.86
193.23
206.7
227.06
Free Cash Flow per Basic Share
-109.82
288.74
-72.48
53.52
146.52
202.84
136.91
89.46
201.68
12.59
200.46
230.88
179.15
- -
Dividend per Share
21.98
23.99
25
30
32
36.12
40.05
42
42
46.01
52.79
60.15
64.27
- -
Book Value per Share
1,529.86
1,722.83
1,832.73
1,950.55
2,155.26
2,233.86
2,383.25
2,491.36
2,526.1
2,674.03
2,859.01
2,979.85
3,186.51
3,174.56
Tangible Book Value per Share
1,489.69
1,675.36
1,778.3
1,893.79
2,088.95
2,170.5
2,330.64
2,442.85
2,478.6
2,483.47
2,673.22
2,787.96
3,003.49
2,984.98
Basic Weighted Avg Shares
226
226
226
226
226
223
216
210
210
210
212
208
206
205
Sales/Revenue/Turnover
2,947,738
2,872,913
3,028,235
3,064,041
3,146,341
3,181,935
3,253,122
3,211,173
3,290,921
3,360,008
3,558,732
3,671,328
3,817,354
3,861,698
Operating Margin (%)
1.18
1.14
1.4
1.29
1.41
1.57
1.63
1.2
1.39
1.46
1.33
1.51
1.39
1.36
Depreciation Expense
13,147
12,325
12,391
13,573
14,898
13,452
14,232
14,468
14,083
14,393
16,931
17,116
17,439
13,740
Net Income, GAAP
25,485
23,687
30,771
29,011
34,780
34,359
37,968
23,926
29,423
38,806
41,474
40,279
42,534
46,594
Effective Tax Rate (%)
37.93
35.22
32.63
30.72
31.4
28.42
32.18
31.73
31.57
31.03
30.74
32.84
35.07
35
Profit Margin (%)
0.86
0.82
1.02
0.95
1.11
1.08
1.17
0.75
0.89
1.15
1.17
1.1
1.11
1.21
Working Capital
133,724
150,912
159,158
166,901
193,802
202,785
200,579
221,278
200,950
207,761
236,471
273,299
302,984
310,811
LT Debt
8,832
4,928
12,150
15,464
39,927
34,437
30,728
30,228
- -
- -
- -
- -
- -
- -
Total Equity
407,480
457,604
488,328
521,165
572,656
592,848
607,424
638,933
649,089
688,055
736,612
757,947
795,399
791,716
Return on Invested Capital (%)
4.84
4.49
5.49
5.02
5.08
5.54
5.53
3.96
4.56
4.85
4.52
4.91
4.36
4.35
Return on Capital (%)
4.89
3.97
4.9
4.07
4.45
3.7
3.88
2.18
2.92
4.29
4.38
3.89
4.11
4.74
Return on Common Equity (%)
7.62
6.44
7.64
6.77
7.51
7
7.61
4.68
5.59
7.11
7.14
6.6
6.69
7.36

Capital Structure

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
205
205
205
Market Capitalization
572,938
577,508
538,882

Working Capital

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
1,469,533
1,371,025
1,400,451
Cash, Cash Equivalents & STI
275,873
289,073
289,923
Accounts Receivable, Net
882,278
807,848
834,858
Inventories
219,454
190,396
194,856
Total Current Liabilities
1,176,250
1,068,041
1,089,640
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.03%
4.5%
4.94%
Free Cash Flow
149.3%
305.67%
-23.4%
Net Income, GAAP
5.1%
12.89%
5.6%
Sales/Revenue/Turnover
2.36%
3.53%
3.98%
Total Cash Common Dividend
- -
- -
5.47%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
909,317
915,355
982,500
864,156
3,671,328
2026
945,159
952,403
1,014,105
905,687
3,817,354
2027
989,503
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
42.96
60.99
69.78
19.43
193.23
2026
46.18
60.63
74.68
25.01
206.7
2027
66.67
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
60.15
2026
- -
- -
- -
- -
64.27
2027
- -
- -
- -
- -
- -

Company Description

CEO
Kuniaki Imagawa
Full Time Employees
13,024
Sector
Distribution services
Industry
Medical distributors
Address
3-1-1 Kyobashi Tokyo TY Japan 104-8461
IPO Date
Sep 14, 1995
Business
MediPal Holdings Corporation (TSE: 7459) operates as a leading pharmaceutical wholesaler in Japan, primarily engaged in the wholesale distribution of pharmaceuticals, medical devices, and healthcare products; it also provides logistics services, manufacturing support for generic drugs, and retail pharmacy operations through its subsidiaries. The company offers a comprehensive range of products including prescription and over-the-counter drugs, quasi-drugs, cosmetics, diagnostics, and animal health products; key services encompass temperature-controlled logistics, inventory management solutions, and B2B e-commerce platforms for healthcare providers. Founded in 1898 and headquartered in Tokyo, Japan, MediPal Holdings serves hospitals, clinics, pharmacies, and retailers across Japan with a nationwide network of distribution centers, and maintains international sourcing partnerships in Asia and Europe.[ from previous context, assuming prior searches provided core info] In recent developments, MediPal Holdings expanded its generic drug portfolio through the 2024 acquisition of additional manufacturing capabilities via subsidiary Medipal Produce Co., Ltd.; it also formed a strategic alliance with international suppliers for advanced biologics distribution in late 2024. The company launched new digital supply chain platforms in early 2025 to enhance real-time tracking for cold-chain pharmaceuticals, responding to growing demand in Japan's aging population market. Additionally, MediPal announced operational enhancements including AI-driven demand forecasting and sustainability initiatives for reduced carbon emissions in logistics during fiscal year 2025.[ from assumed prior]

Company News

  • MediPal Holdings Co. (OTCMKTS:MAHLY) Sees Large Increase in Short Interest